Merck & Co. Inc. (MRK): Price and Financial Metrics

Merck & Co. Inc. (MRK): $125.74

0.41 (-0.33%)

POWR Rating

Component Grades








Add MRK to Watchlist
Sign Up

MRK Price/Volume Stats

Current price $125.74 52-week high $133.10
Prev. close $126.15 52-week low $99.14
Day low $125.10 Volume 7,369,900
Day high $127.11 Avg. volume 8,446,840
50-day MA $126.13 Dividend yield 2.43%
200-day MA $112.34 Market Cap 318.45B

MRK Stock Price Chart Interactive Chart >

Merck & Co. Inc. (MRK) Company Bio

Merck & Co., Inc.d.b.a. Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891.(Source:Wikipedia)

MRK Latest News Stream

Event/Time News Detail
Loading, please wait...

MRK Latest Social Stream

Loading social stream, please wait...

View Full MRK Social Stream

Latest MRK News From Around the Web

Below are the latest news stories about MERCK & CO INC that investors may wish to consider to help them evaluate MRK as an investment opportunity.

5 Biggest Lawsuits in 2023 That Could Hit Your Wallet

From the resumption of student loan repayments to charges against the world's largest cryptocurrency exchange, several 2023 court cases could affect consumers.

Yahoo | December 28, 2023

Merck & Co., Inc. (NYSE:MRK) Shares Could Be 50% Below Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Merck fair value estimate is US$215 Merck is estimated to be...

Yahoo | December 28, 2023

20 Most Expensive Drugs in the World

In this article, we will take a look at the 20 most expensive drugs in the world. If you want to skip our discussion on the pharmaceutical industry, you can go directly to the 5 Most Expensive Drugs in the World. The health of the global population is being adversely affected due to numerous factors, […]

Yahoo | December 27, 2023

Rethinking Immunotherapy for Cancer: When Is the Best Time to Stop?

Immune-boosting drugs extend cancer patients’ lives and deliver billions in sales to drugmakers, but some patients might be getting more of the drugs than they need.

Yahoo | December 26, 2023

January Effect: 3 Under-the-Radar Stocks Poised for a New Year Jump

Are you looking to profit from the January effect?

Yiannis Zourmpanos on InvestorPlace | December 24, 2023

Read More 'MRK' Stories Here

MRK Price Returns

1-mo 3.58%
3-mo 6.67%
6-mo 22.54%
1-year 11.77%
3-year 80.46%
5-year 84.40%
YTD 16.07%
2023 1.01%
2022 49.42%
2021 -2.91%
2020 -7.20%
2019 22.27%

MRK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MRK Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!